AstraZeneca Settles Class Action Lawsuit for $103 Million

AstraZeneca has agreed to pay $103 million to settle class-action claims arising out of the company inflating the wholesale price of cancer and asthma treatments. The first settlement includes $13 million for consumers and health insurers in Massachusetts, and $90 million for claimants outside the state. The lawsuit alleged that AstraZeneca inflated the average wholesale price of Zoladex, a cancer drug, and Pulmicort Respules, a treatment used to prevent asthma symptoms in children.


Leave a Reply

Your email address will not be published. Required fields are marked *